Dermapharm Holding SE buy Shooter
Summary
This prediction is currently active. The BUY prediction by Shooter for Dermapharm Holding SE is performing very badly with a performance of -34.14%. This prediction currently runs until 16.05.24. The prediction end date can be changed by Shooter at any time. Shooter has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Dermapharm Holding SE | -4.970% | -4.970% |
iShares Core DAX® | 0.961% | -2.210% |
iShares Nasdaq 100 | 2.626% | -1.918% |
iShares Nikkei 225® | 0.217% | -7.216% |
iShares S&P 500 | 1.540% | -1.858% |